TLDRocket
Sign in

Andrew Blevins

Person ● Covered in 0 stories + Follow ✴ AI Graph Request update

Andrew Blevins is the CTO and co-founder of Leash Bio. Leash Bio describes him as a drug discovery executive and medicinal chemistry leader with more than 16 years of experience. He is known there for his background in drug discovery and medicinal chemistry.

Updated 15 October 2026

Public sources: leash.bio

Why this page exists, and how to correct or remove it

This profile is assembled automatically because Andrew Blevins appears in coverage we index or holds a role listed publicly by their organisation. It uses only public sources — company and organisation pages, news articles, Wikipedia, and public professional listings — and the biography, if any, is written by AI from those sources and cited above.

We hold it to report on the AI industry, under the legitimate interest of journalistic reporting. You can ask us to correct it, restrict it, or take it down, and you can object at any time — no account needed, no reason required.

Claim or correct this profile Request removal How we handle personal data

The daily briefing

Every AI story that matters, in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.